Letter to the editor: Immunomodulation by phosphodiesterase-4 inhibitor in COVID-19 patients

Detalles Bibliográficos
Autores principales: Santaniello, Alessandro, Vigone, Barbara, Beretta, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832456/
https://www.ncbi.nlm.nih.gov/pubmed/32574572
http://dx.doi.org/10.1016/j.metabol.2020.154300
_version_ 1783641840051814400
author Santaniello, Alessandro
Vigone, Barbara
Beretta, Lorenzo
author_facet Santaniello, Alessandro
Vigone, Barbara
Beretta, Lorenzo
author_sort Santaniello, Alessandro
collection PubMed
description
format Online
Article
Text
id pubmed-7832456
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Author(s). Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-78324562021-01-26 Letter to the editor: Immunomodulation by phosphodiesterase-4 inhibitor in COVID-19 patients Santaniello, Alessandro Vigone, Barbara Beretta, Lorenzo Metabolism Article The Author(s). Published by Elsevier Inc. 2020-09 2020-06-20 /pmc/articles/PMC7832456/ /pubmed/32574572 http://dx.doi.org/10.1016/j.metabol.2020.154300 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Santaniello, Alessandro
Vigone, Barbara
Beretta, Lorenzo
Letter to the editor: Immunomodulation by phosphodiesterase-4 inhibitor in COVID-19 patients
title Letter to the editor: Immunomodulation by phosphodiesterase-4 inhibitor in COVID-19 patients
title_full Letter to the editor: Immunomodulation by phosphodiesterase-4 inhibitor in COVID-19 patients
title_fullStr Letter to the editor: Immunomodulation by phosphodiesterase-4 inhibitor in COVID-19 patients
title_full_unstemmed Letter to the editor: Immunomodulation by phosphodiesterase-4 inhibitor in COVID-19 patients
title_short Letter to the editor: Immunomodulation by phosphodiesterase-4 inhibitor in COVID-19 patients
title_sort letter to the editor: immunomodulation by phosphodiesterase-4 inhibitor in covid-19 patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832456/
https://www.ncbi.nlm.nih.gov/pubmed/32574572
http://dx.doi.org/10.1016/j.metabol.2020.154300
work_keys_str_mv AT santanielloalessandro lettertotheeditorimmunomodulationbyphosphodiesterase4inhibitorincovid19patients
AT vigonebarbara lettertotheeditorimmunomodulationbyphosphodiesterase4inhibitorincovid19patients
AT berettalorenzo lettertotheeditorimmunomodulationbyphosphodiesterase4inhibitorincovid19patients

Ejemplares similares